Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(23/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(23/week)
News
United States
(534/week)
Manufacturing
(381/week)
Energy
(301/week)
Technology
(425/week)
Other Manufacturing
(319/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Veloxis Pharmaceuticals A/S
Nov 12, 2019
Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2019
Oct 30, 2019
Veloxis Increases Outlook for 2019 Based on Continued Strong Performance
Jul 22, 2019
Veloxis Revises Outlook for 2019 Based on Strong Performance
Feb 27, 2019
Veloxis Pharmaceuticals Releases Annual Report for 2018
Jan 02, 2019
Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals
Nov 14, 2018
Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2018 Highlights
Oct 31, 2018
Ira Duarte Promoted to Chief Financial Officer of Veloxis Pharmaceuticals A/S
Oct 10, 2018
Veloxis to Present at the Jefferies 2018 London Healthcare Conference
Aug 13, 2018
Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2018
Jun 04, 2018
Veloxis Partners with the American Society of Transplant Surgeons to Award First Annual ASTS-Veloxis Fellowship in Transplantation
Apr 20, 2018
FDA Accepts Veloxis's Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR®
Apr 13, 2018
Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2018
Apr 03, 2018
Veloxis Appoints Morten Marott as Chief Financial Officer
Mar 28, 2018
Veloxis Announces the Publication of ASERTAA (A Study of Extended Release Tacrolimus in African-Americans), a Phase IIIb study of ENVARSUS XR®
Mar 07, 2018
Veloxis Files with FDA for the De Novo Indication for ENVARSUS XR®
Feb 27, 2018
Veloxis Pharmaceuticals Releases Annual Report for 2017
Feb 14, 2018
Veloxis Secures $60M in Debt Financing
Jun 06, 2017
Veloxis Pharmaceuticals A/S Announces Agreement for Taiba Healthcare to Commercialize Envarsus XR in the Middle East and North Africa Region
Jun 06, 2017
Veloxis Pharmaceuticals A/S and Endo Ventures Limited Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Envarsus XR® in Canada
Jun 06, 2017
Veloxis Pharmaceuticals A/S Announces Agreement with Chiesi Farmaceutici S.p.A. to Commercialize Envarsus XR in China
Latest News
May 1, 2024
Leeward Renewable Energy Operations Announces the Posting of Year End 2023 Financial Results and May 10...
May 1, 2024
Itron Enhances Temetra® Platform to Maximize Business Value for Water Utilities in Australia and New Zealand
May 1, 2024
Imperial reports voting results for election of directors
May 1, 2024
Microvast Schedules First Quarter Earnings Call
May 1, 2024
Magellan Aerospace Announces Quarterly Dividend
May 1, 2024
Magellan Aerospace Announces Report on Voting Results for Directors
May 1, 2024
Hyliion Holdings Reports First-Quarter 2024 Financial Results
May 1, 2024
PACCAR Increases Regular Quarterly Dividend
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events